Poster 427 Pharmacodynamic Effects From a Category 3 Intranasal Human Abuse Potential Study of an Abuse-Deterrent, Extended-Release Morphine Product Candidate in Nondependent, Recreational Opioid Users.
PRA Health Sciences, South Salt Lake, UT, United States.
Lynn R
LR
Webster
Michael D
MD
Smith
John
J
Lawler
Karsten
K
Lindhardt
Jeffrey M
JM
Dayno